Octapharma AG: Publication of data from WIL-31 study marks a

Octapharma AG: Publication of data from WIL-31 study marks a milestone in improving long-term care for patients with severe von Willebrand disease (VWD)

Octapharma AG: Publication of data from WIL-31 study marks a milestone in improving long-term care for patients with severe von Willebrand disease (VWD)

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Sweden , Germany , France , Willebrand , Nordrhein Westfalen , Austria , Switzerland , Lachen , Switzerland General , Robertf Sidonio Jr , Stefan Klotter , Ivana Spotakova , Prnewswire Octapharma , Sigurd Knaub , Global Communications , Aflac Cancer Blood Disorders Center , Blood Advances , Principal Investigator , Medical Director , Aflac Cancer , Blood Disorders Center , Associate Professor , Emory University School , Full Prescribing Information , Product Characteristics , Die Performance Strategie , Assets Sie ,